Cardiovascular magnetic resonance in pregnancy: Insights from the cardiac hemodynamic imaging and remodeling in pregnancy (CHIRP) study by Robin A Ducas et al.
Ducas et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:1
http://jcmr-online.com/content/16/1/1RESEARCH Open AccessCardiovascular magnetic resonance in pregnancy:
Insights from the cardiac hemodynamic imaging
and remodeling in pregnancy (CHIRP) study
Robin A Ducas1†, Jason E Elliott2†, Steven F Melnyk3, Sheena Premecz3, Megan daSilva3, Kelby Cleverley3,
Piotr Wtorek3, G Scott Mackenzie4, Michael E Helewa2 and Davinder S Jassal1,3,5*Abstract
Background: Cardiovascular disease in pregnancy is the leading cause of maternal mortality in North America.
Although transthoracic echocardiography (TTE) is the most widely used imaging modality for the assessment of
cardiovascular function during pregnancy, little is known on the role of cardiovascular magnetic resonance (CMR).
The objective of the Cardiac Hemodynamic Imaging and Remodeling in Pregnancy (CHIRP) study was to compare
TTE and CMR in the non-invasive assessment of maternal cardiac remodeling during the peripartum period.
Methods: Between 2010–2012, healthy pregnant women aged 18 to 35 years were prospectively enrolled. All
women underwent TTE and CMR during the third trimester and at least 3 months postpartum (surrogate for
non-pregnant state).
Results: The study population included a total of 34 women (mean age 29 ± 3 years). During the third trimester,
TTE and CMR demonstrated an increase in left ventricular end-diastolic volume from 95 ± 11 mL to 115 ± 14 mL
and 98 ± 6 mL to 125 ± 5 mL, respectively (p < 0.05). By TTE and CMR, there was also an increase in left ventricular
(LV) mass during pregnancy from 111 ± 10 g to 163 ± 11 g and 121 ± 5 g to 179 ± 5 g, respectively (p < 0.05).
Although there was good correlation between both imaging modalities for LV mass, stroke volume, and cardiac
output, the values were consistently underestimated by TTE.
Conclusion: This CMR study provides reference values for cardiac indices during normal pregnancy and the
postpartum state.
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Cardiovascular disease in pregnancy is the leading cause
of maternal morbidity and mortality in North America
[1,2]. In the developed world, hypertension, arrhythmias,
valvular heart disease, heart failure, and other acquired
diseases of the maternal circulation can severely impact
pregnancies [1]. A growing number of women with pre-* Correspondence: djassal@sbgh.mb.ca
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stated.existing congenital heart disease also require cardiac
consultation and imaging as part of their pre-conception
planning [3]. As the hemodynamic changes of pregnancy
may be poorly tolerated in a woman with pre-existing
heart disease, adequate evaluation of a woman’s cardiac
status using cardiac imaging is often necessary to ensure
optimal maternal and fetal outcomes.
The maternal cardiovascular system is subject to a re-
versible series of structural and functional adaptations
during pregnancy. While these changes are normally
well tolerated in healthy women, they can present a ser-
ious challenge to pregnant women with underlying car-
diovascular disease. Driving these normal hemodynamic
changes of pregnancy is a fall in systemic vasculartd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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and a low-resistance utero-placental circulation [4-6].
Mean arterial pressure falls during the first half of preg-
nancy, then rises to pre-pregnant levels by term. Plasma
volume increases by up to 50% as a result of avid salt
and water retention [7,8]. The combination of decreased
left ventricular (LV) afterload, increased preload, and a
concomitant increase in resting heart rate leads to an
increase in cardiac output (CO) over the same period
[4,9-16]. Varying degrees and patterns of secondary
atrial enlargement and ventricular hypertrophy have
been described during pregnancy, along with increases
in the cross-sectional areas of the mitral, pulmonic, and
tricuspid valves [17]. In the postpartum period, the
physiologic adaptations of pregnancy undergo reversal
to their pre-pregnant state, mostly occurring shortly
after delivery [15].
Various diagnostic imaging methods have been used to
characterize the hemodynamic and structural adapta-
tions of the maternal cardiovascular system during and
after pregnancy. These methods range from the invasive
dye-dilution technique in 1915 [18], the Cournand cardiac
catheterization technique with the direct Fick method in
the late 1940s [19,20], M-mode echocardiography begin-
ning in the 1960s and refined with pulsed-wave Doppler
[21], and more recently, Swan-Ganz pulmonary artery
catheterization [22]. Currently, transthoracic echocardiog-
raphy (TTE) is the most commonly used non-invasive car-
diac imaging modality during pregnancy. Transthoracic
echocardiography has several advantages as an imaging
modality including its widespread availability, portability,
excellent temporal resolution, and lack of radiation expos-
ure. However, TTE has a number of notable limitations,
including moderate intra- and inter-observer variability
[23], use of geometric assumptions that may not accur-
ately describe the maternal heart during pregnancy
[23,24], and poor image quality in individuals with in-
creased body habitus or poor acoustic windows.
In contrast, cardiovascular magnetic resonance (CMR)
is highly reproducible and accurate in the determination
of cardiac volumes, and is not limited by variations in
ventricular geometry, body habitus, or exposure to ioniz-
ing radiation [25,26]. CMR is considered to be a safe im-
aging modality in pregnancy for both the mother and
fetus [27,28]. There have been no harmful effects found
of in utero exposure to CMR in children up to 9 years
of follow-up [29,30]. CMR has recently been utilized in
the clinical management of aortic dissection, peripar-
tum cardiomyopathy, congenital valvular lesions and
other maternal cardiac disease states during pregnancy
and the postpartum period [31-39]. However, the role of
CMR in the non-invasive assessment of maternal car-
diac adaptation during normal, healthy pregnancies re-
mains ill defined. Establishing reliable structural andhemodynamic CMR reference values for normal preg-
nancies is of benefit in interpreting abnormal changes
observed in maternal cardiovascular disease states, as
well as in the management of pregnant patients with
pre-existing cardiac disease.
The objective of the Cardiac Hemodynamic Imaging
and Remodeling in Pregnancy (CHIRP) study was to
compare TTE and CMR in the non-invasive assessment




This was a prospective cohort study (November 1, 2010-
September 1, 2012 inclusive) of healthy volunteers re-
cruited from prenatal obstetric clinics at two tertiary
care centres. Eligible subjects were between the ages of
18 and 35 years old at their last normal menstrual
period, carrying a healthy singleton pregnancy, and had
no previous pregnancy carried beyond 14 weeks gesta-
tional age. Exclusion criteria included multiple gestation;
any history of cardiac disease or cardiac surgery; any
history of thyroid disease, hypertension or diabetes; any
significant pregnancy-related complications including
gestational diabetes, gestational hypertension, or pre-
eclampsia; and/or the presence of pacemakers, surgical
clips or other contraindications to CMR. Cardiac im-
aging by both TTE and CMR was performed in all pa-
tients at two time points: initially in the third trimester
and then again approximately three months postpartum.
Postpartum imaging was performed as a surrogate for
the baseline non-pregnant cardiovascular state and used
for comparison with third trimester imaging data. The
University of Manitoba Human Research Ethics Board
approved the study protocol and informed consent was
obtained from all patients.
Echocardiography
Standard TTE (Vivid 7, GE Healthcare, Milwaukee, WI,
US) with a multi-frequency transducer and tissue Doppler
imaging (TDI) capability was performed in all patients. All
TTE scans were performed with women in the left lateral
decubitus position to minimize aorto-caval compression
and improve patient comfort in the third trimester. The
parasternal long axis view was used to obtain cardiac di-
mensions for the LV, right ventricle (RV), interventricular
septum (IVS), posterior wall thickness (PWT), left atrium
(LA) and ascending aorta. The apical four chamber and
two chamber views were used to obtain LV end systolic
volume (LVESV) and LV end diastolic volume (LVEDV)
by manually tracing the endocardium. These measure-
ments allowed for calculation of the LV ejection fraction
(LVEF) and stroke volume (SV) using the biplane modified
Simpson’s method [40]. Left and right atrial volumes (LA
Table 1 Clinical characteristics of study population
(n = 34)
Maternal age at LNMP, years 29 ± 3
Pre-pregnancy BMI, kg/m2 24 ± 4
Pre-pregnancy BSA, m2 1.7 ± 0.2
Baseline BP (systolic), mmHg 112 ± 10
Baseline BP (diastolic), mmHg 68 ± 8
Vaginal delivery, n (%) 26 (77%)
Birth weight, g 3269 ± 400
GA at delivery, days 278 ± 9
GA at third trimester imaging, days 237 ± 16
Days postpartum at baseline imaging, days 107 ± 25
Data are expressed as mean ± SD or number (percentage). BSA, body surface
area; BMI, body mass index; BP, blood pressure; GA, gestational age; LNMP, last
normal menstrual period.
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view at end-systole using the area length method. The
calculation of LV mass using LV linear dimensions was
performed according to the American Society of Echo-
cardiography recommendations [40]. Diastolic function
was evaluated using pulsed wave Doppler obtained at
the level of the mitral valve, assessing peak early (E) and
late (A) mitral inflow velocities, isovolumetric relaxation
time (IVRT) and deceleration time (DT). The E/A ratio
was calculated as a marker of diastolic function. Tissue
Doppler measurements of systolic (S’), early (E’) and late
(A’) tissue velocities were obtained at the medial and lat-
eral mitral annulus. The dimensionless E/E’ ratio was
calculated as a non-invasive measure of LV filling pres-
sure [41]. Two observers (RD and DJ), blinded to the
clinical data, analyzed the echocardiographic images off-
line using EchoPAC PC (version 110.0.0, GE Healthcare,
Milwaukee, WI, US).
Cardiovascular magnetic resonance
The serial CMR scans were performed using a 1.5 Tesla
Siemens Scanner (Sonata, Magnetom, Siemens, Erlangen,
Germany). Breath-hold cine imaging was performed using
a segmented TrueFISP sequence (temporal resolution
25 ms, slice thickness 8 mm, interslice gap 4 mm, spatial
resolution 117 × 192, field of view 360 mm, and GRAPPA
parallel imaging) with ECG gating to obtain images repre-
sentative of the entire cardiac cycle in both long and short
axis views. A combination of a 32 channel spine matrix
and 6 channel body matrix coil was used. All patients were
imaged in a half left lateral decubitus position to minimize
aorto-caval compression and improve patient comfort in
the third trimester. There were no sedative medications or
contrast agents used during this study. Chamber measure-
ments were obtained from the three and four chamber
long axis views. Measurement of the aortic sinus, sinotub-
ular junction, and ascending aorta were performed in both
the three-chamber and coronal views. Endocardial and
epicardial contours were drawn manually for the LV and
RV, respectively, at end-systole and end-diastole in each
data set with the most basal short axis slice identified as
the image which contains at least 50% of circumferential
myocardium. Papillary muscles and trabeculations were
included in LV and RV mass calculation. Two observers
(RD and DJ), blinded to the clinical data, analyzed the
CMR images offline using CMR analysis suite (version
3.4.0, Circle Cardiovascular Imaging, Calgary, Alberta,
Canada).
Statistical analysis
All parametric data was reported as mean ± standard devi-
ation (SD). Categorical data was reported as “n” (percent-
age). Comparison of non-pregnant and third trimester
means for each imaging modality was performed using apaired Student’s t-test. Linear regression analyses were
performed to assess the correlation between TTE and
CMR for CO, stroke volume (SV) and LV mass. Bland-
Altman plots of difference versus mean were performed
for CO, SV and LV mass with 95% agreement limits of ±
1.96 SD. The Mann–Whitney U test was used to measure
the intra and inter-observer variability for LVEDV and LV
mass for both imaging modalities. Statistical significance
was defined as p < 0.05. SAS version 8.01 (SAS Institute
Inc., Cary, NC, US) was used to perform the analysis.
Results
Study population
The baseline clinical characteristics of the study population
(n = 34) are summarized in Table 1. The mean maternal
age at the last normal menstrual period was 29 ± 3 years
with a mean pre-pregnancy BMI of 24 ± 4 kg/m2. The
mean gestational age at third trimester imaging was 237 ±
16 days (34 weeks ± 16 days) and mean number of days for
postpartum imaging was 107 ± 25 days (16 weeks ±
25 days).
Left ventricular geometry and systolic function
The structural and systolic functional parameters for
both imaging modalities in the third trimester and post-
partum (baseline) settings are summarized in Table 2.
There was a statistically significant increase in LV end
diastolic diameter (LVEDD) and LVEDV in the third
trimester using both TTE and CMR, with narrower con-
fidence intervals using CMR. Both TTE and CMR dem-
onstrated a statistically significant increase in LV mass
in the third trimester. By TTE, there was an increase in
LV mass from 111 ± 10 g to 163 ± 11 g, representing a
47% increase above baseline values. Similarly, CMR dem-
onstrated a 48% increase in LV mass over the same period,
from 121 ± 5 g to 179 ± 5 g, with tighter confidence inter-
vals. The increase in heart rate (HR) and SV between
Table 2 Left and right ventricular parameters by TTE and CMR at baseline (postpartum) and the third trimester in total
population (n = 34)
TTE CMR
Baseline Third trimester P Baseline Third trimester P
(postpartum) (postpartum)
LV parameters
LVEDD (mm) 45 ± 4 52 ± 3* <0.05 46 ± 1 55 ± 2* <0.05
LVESD (mm) 31 ± 2 33 ± 4 0.81 32 ± 2 32 ± 3 0.85
LVEDV (mL) 94 ± 10 114 ± 12* <0.05 99 ± 6 128 ± 5* <0.05
LVESV (mL) 30 ± 7 30 ± 9 0.83 32 ± 4 33 ± 6 0.81
IVS (mm) 9 ± 1 9 ± 2 0.92 8 ± 1 8 ± 1 1.00
PWT (mm) 9 ± 1 9 ± 1 1.00 8 ± 1 8 ± 1 1.00
SV (mL) 62 ± 12 85 ± 8* <0.05 68 ± 7 97 ± 6* <0.05
HR (bpm) 60 ± 12 74 ± 9* <0.05 62 ± 8 79 ± 4* <0.05
CO (L/min) 3.5 ± 0.8 6.3 ± 0.7* <0.05 4.0 ± 0.3 7.4 ± 0.4* <0.05
LVEF (%) 68 ± 7 70 ± 8 0.68 62 ± 4 63 ± 6 0.42
LV mass (g) 111 ± 10 163 ± 11* <0.05 121 ± 5 179 ± 5* <0.05
RV parameters
RVEDD (mm) 32 ± 6 39 ± 3* <0.05 33 ± 4 39 ± 3* <0.05
RVEDV - - - 93 ± 4 115 ± 4* <0.05
RVEF (%) - - - 62 ± 3 61 ± 3 0.82
RV mass (g) - - - 51 ± 5 71 ± 6* <0.05
RV FAC (%) 43 ± 6 44 ± 5 0.81 - - -
TAPSE (cm) 3.0 ± 0.2 3.1 ± 0.4 0.76 - - -
PASP (mmHg) 25 ± 4 30 ± 5 0.67 - - -
Data are expressed as mean ± SD. CO, cardiac output; HR, heart rate; IVS, interventricular septum; LV, left ventricle; LVEDD, left ventricular end-diastolic diameter;
LVEF, LV ejection fraction; LVEDV, LV end-diastolic volume; LVESD, LV end-systolic diameter; LVESV, LV end-systolic volume; PASP, pulmonary artery systolic pressure;
PWT, posterior wall thickness; RV, right ventricle; RVEDD, right ventricular end-diastolic diameter; RVEF, RV ejection fraction; RV FAC, fractional area change; SV,
stroke volume; TAPSE, tricuspid annular plane systolic excursion; *P < 0.05, third trimester vs. baseline within each imaging modality.
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aging modalities, resulted in an appropriate increase in
CO during pregnancy. Using TTE and CMR, there was an
increase in CO from 3.5 ± 0.8 L/min to 6.3 ± 0.7 L/min
and from 4.0 ± 0.3 L/min to 7.4 ± 0.4 L/min, respectively
(p < 0.05) (Table 2).
Linear regression analysis for SV, CO and LV mass
demonstrated good correlation between both TTE and
CMR at baseline and in the third trimester as shown in
Figure 1. The baseline R-values for SV, CO and LV mass
were 0.85, 0.82 and 0.59, respectively. In the third tri-
mester, the R-values for SV, CO and LV mass were 0.83,
0.81 and 0.67, respectively. The Bland-Altman plots for
the same parameters are shown in Figure 2. At both
time points, TTE showed a slightly negative bias on the
Bland-Altman plots in the assessment of SV, CO and LV
mass as compared to CMR.
Right ventricular geometry and systolic function
The RV end diastolic diameter (RVEDD) increased signifi-
cantly from the non-pregnant state to the third trimester,as determined by both TTE (32 ± 5 mm to 39 ± 3 mm)
and by CMR (33 ± 4 mm to 39 ± 3 mm) (Table 2). RV
mass as analyzed by CMR increased from a mean of 51 ±
5 g at baseline to 71 ± 6 g in the third trimester (p < 0.05),
while RV volume increased from 93 ± 4 mL to 115 ± 4 mL
(p < 0.05). There was no change in the RV systolic function
as measured by TTE or CMR.
Atrial and aortic root geometry
Both LA and RA enlargement was observed from the
non-pregnant state to the third trimester, using TTE and
CMR (Table 3). The LA end systolic volume measured
by CMR increased by approximately 50% from 32 ±
3 mL to 48 ± 3 mL in the third trimester. Similarly, the
RA end systolic volume measured by CMR increased by
55% from 29 ± 2 mL to 45 ± 4 mL. A smaller degree of
biatrial enlargement was observed using TTE.
There was no statistically significant change in aortic
root or ascending aortic dimensions demonstrated from
non-pregnant to third trimester imaging using either
TTE or CMR (Table 3).
Figure 2 Bland-Altman plots comparing TTE and CMR assessments of stroke volume (SV), cardiac output (CO) and left ventricular (LV)
mass in baseline and third trimester states. Plots demonstrate TTE tending to underestimate the parameters as compared to CMR. Solid lines
indicate mean difference (bias); dotted lines indicate 95% confidence intervals.
Figure 1 Linear regression plots demonstrating good correlation between TTE and CMR for the assessment of stroke volume (SV),
cardiac output (CO) and left ventricular (LV) mass at baseline and in the third trimester.
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Table 3 Atrial and aortic parameters by TTE and CMR at baseline (postpartum) and the third trimester in total
population (n = 34)
TTE CMR
Baseline Third trimester P Baseline Third trimester P
(postpartum) (postpartum)
Atrial parameters
LA diameter (mm) 32 ± 3 38 ± 3* <0.05 31 ± 3 40 ± 3* <0.05
LA volume (mL) 31 ± 5 43 ± 6* <0.05 32 ± 3 48 ± 3* <0.05
RA volume (mL) 29 ± 3 39 ± 7* <0.05 29 ± 2 45 ± 4* <0.05
Aortic diameters
Sinuses (mm) 33 ± 1 33 ± 4 0.81 33 ± 2 32 ± 2 0.81
Sinotubular junction (mm) 30 ± 2 30 ± 4 0.75 32 ± 2 30 ± 2 0.79
Ascending aorta (mm) 31 ± 3 31 ± 3 0.73 31 ± 2 32 ± 3 0.80
Data are expressed as mean ± SD. LA, left atrial; RA, right atrial. *P < 0.05, third trimester vs. baseline within each imaging modality.
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Diastolic parameters obtained by TTE are outlined in
Table 4. There was an increase in trans-mitral A wave
velocity from 0.7 ± 0.1 cm/s to 1.3 ± 0.2 cm/s from the
non-pregnant state to the third trimester (p < 0.05).
The A wave increase resulted in a decreased E/A ratio
in the third trimester from 1.3 ± 0.1 cm/s to 0.7 ±Table 4 Diastolic TTE parameters at baseline
(postpartum) and the third trimester in total population
(n = 34)
Baseline (postpartum) Third trimester P
Diastolic parameters
E wave (cm/s) 0.9 ± 0.1 0.9 ± 0.2 0.87
A wave (cm/s) 0.7 ± 0.1 1.3 ± 0.2* <0.05
E/A 1.3 ± 0.1 0.7 ± 0.2* <0.05
DT (ms) 221 ± 17 224 ± 15 0.65
IVRT (ms) 108 ± 10 107 ± 9 0.76
TDI parameters (LV)
Lateral S’ (cm/s) 10.3 ± 0.4 11.2 ± 0.3 0.80
Lateral E’ (cm/s) 8.0 ± 0.8 8.2 ± 0.6 0.77
Lateral A’ (cm/s) 7.8 ± 0.5 7.9 ± 0.4 0.79
Medial S’ (cm/s) 9.8 ± 0.6 9.9 ± 0.5 0.71
Medial E’ (cm/s) 8.1 ± 0.7 8.2 ± 0.6 0.82
Medial A’ (cm/s) 8.0 ± 0.5 8.1 ± 0.4 0.74
Mean E/E’ 11 ± 3 11 ± 2 0.78
TDI parameters (RV)
Lateral S’ 9.4 ± 0.3 9.5 ± 0.4 0.77
Lateral E’ 8.2 ± 0.4 8.1 ± 0.5 0.79
Lateral A’ 7.8 ± 0.4 7.6 ± 0.4 0.80
Data are expressed as mean ± SD. A, late diastolic transmitral velocity; A’, late
diastolic myocardial velocity; E, early diastolic transmitral velocity; E’, early
diastolic myocardial velocity; DT, deceleration time; IVRT, isovolumic relaxation
time; S’, systolic myocardial velocity; TDI, tissue Doppler imaging. *P < 0.05,
third trimester vs. baseline.0.2 cm/s (p < 0.05), consistent with mild diastolic dys-
function. The mitral DT, IVRT, and tissue Doppler pa-
rameters (including E/E’) did not change significantly
from non-pregnant to third trimester imaging.
Intra-observer and inter-observer variability
The intra- and inter-observer variability of LVEDV and
LV mass using both imaging techniques are shown in
Table 5. CMR yielded higher reproducibility of cardiac
dimensions compared to TTE.
Discussion
The diagnostic utility of an imaging modality lies in the
knowledge of normal parameters for each variable studied.
Without a clear understanding of what is considered nor-
mal, diagnosis of disease is challenging, if not impossible.
While normal standards of maternal cardiac structure and
function are well established for TTE, based on studies
conducted since the 1960’s [10-15,17,18,20,41-47] this is
the first study to longitudinally assess normal changes inTable 5 Intra-observer and inter-observer variability for
LVEDV and LV mass
Intra-observer Inter-observer
Absolute % Absolute %
LVEDV (mL)
TTE 11.2 ± 6.3 10.3 ± 4.1 13.1 ± 5.4 9.7 ± 4.2
CMR 7.4 ± 4.2 6.2 ± 3.1 9.3 ± 2.5 6.2 ± 3.0
LV mass (g)
TTE 13.0 ± 3.5 10.4 ± 5.2 12.1 ± 4.3 10.3 ± 3.8
CMR 7.8 ± 3.2 5.9 ± 2.1 9.0 ± 3.2 6.9 ± 2.4
Absolute values are defined as the population mean ± SD of absolute
differences between repeated measurements. % values are defined as the
population mean ± SD of absolute differences of repeated measurements
normalized by the average of the two repeated measurements. CMR,
cardiovasculart MR; LVEDV, left ventricular end-diastolic volume; LV mass, left
ventricular mass; TTE, transthoracic echocardiography.
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using both TTE and CMR. In the current study, we dem-
onstrated an increase in chamber dimensions, LV mass,
SV, and CO by both imaging modalities, with tighter con-
fidence intervals using CMR. There was also evidence of
mild diastolic dysfunction in the third trimester, with no
change in aortic root or ascending aorta measurements.
Although there was good correlation between TTE and
CMR for LV mass, SV and CO, the values were consist-
ently underestimated by echocardiography.
Hemodynamic changes
The maternal cardiovascular system undergoes signifi-
cant physiologic changes in order to support the devel-
oping fetus. Previous studies, using TTE in normal
pregnancy, have reported that the HR typically increases
by 15-20%, SV increases by 20-25%, and CO increases
by 30- 50% [4,9-11,13,15]. In our study, we demon-
strated that the HR increased by approximately 20%, SV
increased by 40%, and CO increased by 80-85% using
TTE and CMR. Although the increase in HR seen in our
study was similar to previous studies, we observed a
greater increase in SV and CO during pregnancy. Recent
improvements in endocardial visualization by both TTE
and CMR, as well as differences in study design and im-
aging time points may account for this finding. To the
best of our knowledge, this is the first study to longitu-
dinally assess CO and SV using CMR in pregnancy,
which is known to have improved accuracy and reprodu-
cibility for assessment of LV volumes [24]. Such findings
may have implications in pre-conception counseling and
managing women with pre-existing heart disease or
myocardial dysfunction in pregnancy.
Left ventricular dimensions and mass
During pregnancy, total blood volume expansion leads
to an increase in ventricular preload and compensatory
structural changes in the LV. The increases in LV vol-
ume and myocardial mass are physiologic adaptations
enabling the maternal heart to support the demands of
the developing fetus. Previous studies have reported an
increase in LVEDV and LV mass in the third trimester,
relative to the non-pregnant state [11,12,14]. In the
current study, using both TTE and CMR, we demon-
strated an increase in LVEDV of 20-30% with an in-
crease in LV mass of 45-50%, similar to previous studies.
Our finding of slightly higher values for LV volume and
mass both at baseline and in the third trimester for
CMR, as compared to TTE, is a reflection of differing
image analysis techniques. Whereas CMR routinely in-
cludes papillary muscles in volume and mass analyses,
they are excluded in echocardiographic measurements
[24,26]. Nonetheless, although TTE consistently under-
estimated LV volumes and mass during the peripartumperiod as compared to CMR, there was good correlation
between both imaging modalities.
Right ventricular dimensions and mass
Although RV dilation is an accepted physiologic change
in pregnancy, poor visualization of this chamber on TTE
and lack of standardized parameters have accounted for
the paucity of data examining RV remodeling during
pregnancy. Whereas quantitative assessment of the RV
using TTE is difficult due to its complex geometry,
CMR serves as the gold standard for non-invasive as-
sessment of this chamber due to its higher spatial reso-
lution and low intra- and inter-observer variability [42].
A previous study using TTE demonstrated an increase
in RVEDD by 18% during the third trimester [17], which
is very similar to the values obtained in our study. Using
CMR in our study, we also provide new reference values
for an increase in RV volume and mass with preserved
RV systolic function during pregnancy. In women with
pre-existing congenital cardiac conditions that involve
the RV, the peripartum use of CMR may be beneficial in
the optimal management of this patient population.
Atrial geometry and diastolic function during pregnancy
During pregnancy, there is physiological dilatation of both
atria due to an increase in the effective circulating blood
volume. Similar to previous studies that demonstrated an
increase in LA volumes by approximately 30% in the third
trimester [10,14,43], our study confirmed LA volume in-
creases of 39% and 50% by TTE and CMR, respectively.
Although few studies have examined RA volumes during
pregnancy, Campos et al. demonstrated a 19% increase in
RA dimensions in the third trimester by TTE [17]. Our
study demonstrated an increase in RA volume of 34% and
55% by TTE and CMR, respectively. With the physio-
logical increase in both atria during pregnancy, compensa-
tory changes in diastolic function occur as well.
Traditional Doppler techniques have been used to
characterize diastolic function in pregnancy. Previous
echocardiographic studies have demonstrated a decline
in the ratio of passive filling to atrial contraction-related
ventricular filling during diastole in pregnant women at
term [44-48]. This decrease in E/A ratio that has been
postulated to reflect mild diastolic dysfunction during
the pregnant state was supported in our current study.
As compared to these conventional measures of diastolic
dysfunction, TDI parameters are independent of preload
and afterload, which are both altered by pregnancy. Our
results reflect no significant change in TDI parameters
during the peripartum state.
Aortic changes
Although TTE is limited in its ability to assess aortic
root and ascending aorta dimensions, CMR can provide
Ducas et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:1 Page 8 of 9
http://jcmr-online.com/content/16/1/1multi-planar reformations of the great vessels allowing
for greater visibility and more accurate quantification
[49]. A recent comparative study of TTE and CMR in
pregnant women with pre-existing aortopathies reported
that CMR altered clinical decision-making in up to 50%
of the study population [35]. Although the clinical utility
of CMR was well reported in this study, no CMR refer-
ence parameters for aortic dimensions during a normal
healthy pregnancy have been previously been estab-
lished. An important new finding of our study was to
provide longitudinal aortic root measurements during
healthy pregnancies using CMR. In our study, we demon-
strated that aortic root and ascending aorta measurements
remain relatively stable during the peripartum state. This
finding may have implications in pre-conception counsel-
ing and managing women with pre-existing aortopathies
in pregnancy.
Limitations
There are several limitations to the current study. First,
we used the postpartum period as a surrogate for the
pre-pregnancy state. This was done for logistical reasons
as predicting when and whom to image pre-conception
to allow creation of a study cohort is neither cost-
effective nor practical. Second, since we did not image
pregnant women during the first and second trimesters,
the degree of structural and functional change in earlier
pregnancy was not determined. We performed imaging
in the third trimester as several studies have shown that
many hemodynamic changes will be fully evolved by
28 weeks gestation [4,9]. Finally, due to the prolonged
length of the CMR examinations for the pregnant women,
CMR-based blood flow velocity measurements were not
obtained and thus could not be compared to the analo-
gous values measured with TTE.
Conclusion
This CMR study provides reference values for cardiac in-
dices during normal pregnancy and the postpartum state.
Future studies are warranted to evaluate the role of CMR
in the assessment of pregnant women with pre-existing
cardiac disease and/or peripartum cardiomyopathy.
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